Self-Administered Treatment in Paroxysmal Supraventricular Tachycardia (PSVT): Clinical and Payer Considerations With CARDAMYST® (Etripamil)November 2nd 2026This publication was sponsored by Milestone Pharmaceuticals, Inc.